Related Experiment Video
Updated: Jun 8, 2026

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
Published on: September 9, 2022
Persistent interferon-ß-1b-induced psychosis in a patient with multiple sclerosis
Giovanni Manfredi1, Giorgio D Kotzalidis, Gabriele Sani
1Psychiatric Unit, Department of Neurosciences, Mental Health and Sensory Functions (NESMOS), Sapienza University, 2nd Medical School, Sant' Andrea Hospital, Rome, Italy. giovanni.manfredi@uniroma1.it
Abstract:
Interferon-ß is used in patients with multiple sclerosis to reduce autoimmunity; although other psychiatric side-effects are common, in contrast to interferon-alpha, psychosis has been reported only once. A patient with multiple sclerosis developed auditory hallucinations, paranoid delusions, and increased aggressiveness after 16 months of treatment with interferon-ß-1b, 250 mg every other day. He responded after about one month to antipsychotic treatment, but tended to relapse upon dose reduction, and after 2 years still needs antipsychotics to control his symptoms. Because there was no change in his magnetic resonance imaging between pre- and post-treatment with interferon, we concluded that psychosis was more related to interferon treatment than to the underlying disease.
Related Concept Videos
Multiple Sclerosis l: Introduction
Inhibitors of Viral Protein Synthesis
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Psychosis and Antipsychotic Drugs: Overview
Psychosis: Goals of Pharmacotherapy
Positive Symptoms Schizophrenia: Hallucinations and Delusions
Hallucinations
Hallucinations in...
